Straits Times Index
3,312.93 +23.51 (+0.71%) Nikkei
38,669.57 +283.84 (+0.74%) Hang Seng
19,271.05 +197.34 (+1.03%) FTSE 100
8,445.80 +17.67 (+0.21%) Bitcoin USD
65,855.37 +4,107.45 (+6.65%) CMC Crypto 200
1,390.27 +122.32 (+9.65%)
HUM Nov 2024 500.000 call
| Previous close | 0.8300 |
| Open | 0.8900 |
| Bid | 1.7500 |
| Ask | 2.0000 |
| Strike | 500.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.8300 - 0.8900 |
| Contract range | N/A |
| Volume | |
| Open interest | 69 |
Business WireCenterWell Specialty Pharmacy Wins National Patient Choice Award
LOUISVILLE, Ky., May 15, 2024--CenterWell Specialty Pharmacy wins national patient choice award for the sixth time in seven years.
Business WireHumana Ranks 6th Overall in Fair360 National Companies for Diversity
LOUISVILLE, Ky., May 15, 2024--Humana Inc. (NYSE: HUM) has ascended to No. 6 on Fair360’s prestigious list of the Top 50 Companies for Workplace Fairness, marking its seventh consecutive year in the top rankings. This significant move up from No. 10 last year showcases Humana's dedication to diversity and inclusion, as recognized by one of the nation's most comprehensive analyses of corporate diversity practices.
Business WireJim Rechtin to Assume Humana CEO Role Effective July 1, 2024
LOUISVILLE, Ky., May 13, 2024--Leading health insurer and health care services company Humana Inc. (NYSE: HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024. As previously announced, Rechtin joined Humana as President and Chief Operating Officer in January as part of a long-planned CEO transition. Since then, he has worked in close partnership with Humana’s current CEO, Bruce Broussard, and has immersed himself in Humana’s o
